Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation

Oncogene

Volumn 23, Issue 17, 2004, Pages 3122-3127

  Hořejší, Zuzana ^a   Falck, Jacob ^a,c   Bakkenist, Christopher J ^b   Kastan, Michael B ^b   Lukas, Jiri ^a   Bartek, Jiri ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

ATM; Cell cycle checkpoints; DNA damage; Ionizing radiation; Nbs1

Indexed keywords

ATM PROTEIN; ISOPROTEIN; MUTANT PROTEIN; NIBRIN; PROTEIN; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IONIZING RADIATION; KINETICS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RADIATION DOSE; RADIATION EXPOSURE; RETROVIRUS; WILD TYPE;

ATAXIA TELANGIECTASIA; BINDING SITES; CELL CYCLE PROTEINS; CELL SURVIVAL; DNA DAMAGE; DNA-BINDING PROTEINS; GENE AMPLIFICATION; HUMANS; KINETICS; NEOPLASMS; NUCLEAR PROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN-SERINE-THREONINE KINASES; RADIATION, IONIZING; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA; UNIDENTIFIED RETROVIRUS;

EID: 2442444916     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207447     Document Type: Article

References (41)

1. Ahn JY, Lee KS, Choi SY and Cho SW. (2000). Cancer Res., 60, 5934-5936.
2. Anderson L, Henderson C and Adachi Y. (2001). Mol. Cell. Biol., 21, 1719-1729.
3. Bakkenist CJ and Kastan MB. (2003). Nature, 421, 486-488.
4. Buscemi G, Savio C, Zannini L, Micciche F, Masnada D, Nakanishi M, Tauchi H, Komatsu K, Mizutani S, Khanna K, Chen P, Concannon P, Chessa L and Delia D. (2001). Mol. Cell. Biol., 21, 5214-5222.
5. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM and Nussenzweig A. (2003). Nat. Cell Biol., 5, 675-679.
6. Cerosaletti KM and Concannon P. (2003). J. Biol. Chem., 278, 21944-21951.
7. D'Amours D and Jackson SP. (2002). Nat. Rev. Mol. Cell. Biol., 3, 317-327.
8. Desai-Mehta A, Cerosaletti KM and Concannon P. (2001). Mol. Cell. Biol., 21, 2184-2191.
9. Dong Z, Zhong Q and Chen PL. (1999). J. Biol. Chem., 274, 19513-19516.
10. Durocher D and Jackson SP. (2001). Curr. Opin. Cell Biol., 13, 225-231.
11. Falck J, Petrini JH, Williams BR, Lukas J and Bartek J. (2002). Nat. Genet., 30, 290-294.
12. Gatei M, Sloper K, Sørensen C, Syljuasen R, Falck J, Hobson K, Savage K, Lukas J, Zhou BB, Bartek J and Khanna KK. (2003). J. Biol. Chem., 278, 14806-14811.
13. Gatei M, Young D, Cerosaletti KM, Desai-Mehta A, Spring K, Kozlov S, Lavin MF, Gatti RA, Concannon P and Khanna K. (2000). Nat. Genet., 25, 115-119.
14. Gatei M, Zhou BB, Hobson K, Scott S, Young D and Khanna KK. (2001). J. Biol. Chem., 276, 17276-17280.
15. Girard PM, Riballo E, Begg AC, Waugh A and Jeggo PA. (2002). Oncogene, 21, 4191-4199.
16. Kastan MB and Lim DS. (2000). Nat. Rev. Mol. Cell. Biol., 1, 179-186.
17. Khanna KK and Jackson SP. (2001). Nat. Genet., 27, 247-254.
18. Kim ST, Lim DS, Canman CE and Kastan MB. (1999). J. Biol. Chem., 274, 37538-37543.
19. Kim ST, Xu B and Kastan MB. (2002). Genes Dev., 16, 560-570.
20. Lee JH, Xu B, Lee CH, Ahn JY, Song MS, Lee H, Canman CE, Lee JS, Kastan MB and Lim DS. (2003). Mol. Cancer Res., 1, 674-681.
21. Lim DS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH and Kastan MB. (2000). Nature, 404, 613-617.
22. Lou Z, Minter-Dykhouse K, Wu X and Chen J. (2003). Nature, 421, 957-961.
23. Lukas C, Falck J, Bartkova J, Bartek J and Lukas J. (2003). Nat. Cell Biol., 5, 255-260.
24. Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI and Bartek J. (1997). Genes Dev., 11, 1479-1492.
25. Matsuoka S, Huang M and Elledge SJ. (2000). Proc. Natl. Acad. Sci. USA, 97, 10389-10394.
26. Mirzoeva OK and Petrini JH. (2001). Mol. Cell. Biol., 21, 281-288.
27. Okada S and Ouchi T. (2003). J. Biol. Chem., 278, 2015-2020.
28. Pear WS, Nolan GP, Scott ML and Baltimore D. (1993). Proc. Natl. Acad. Sci. USA, 90, 8392-8396.
29. Petrini JH and Stracker TH. (2003). Trends Cell Biol., 13, 458-462.
30. Petrini JH. (2000). Curr. Opin. Cell Biol., 12, 293-296.
31. Shiloh Y. (1997). Annu. Rev. Genet., 31, 635-662.
32. Shiloh Y. (2001). Curr. Opin. Genet. Dev., 11, 71-77.
33. Shiloh Y. (2003). Nat. Rev. Cancer, 3, 155-168.
34. Sørensen CS, Lukas C, Kramer ER, Peters JM, Bartek J and Lukas J. (2000). Mol. Cell. Biol., 20, 7613-7623.
35. Sørensen CS, Syljuasen RG, Falck J, Schroeder T, Ronnstrand L, Khanna KK, Zhou BB, Bartek J and Lukas J. (2003). Cancer Cell, 3, 247-258.
36. Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NG, Raams A, Byrd PJ, Petrini JH and Taylor AM. (1999). Cell, 99, 577-587.
37. Thompson LH and Schild D. (2002). Mutat. Res., 509, 49-78.
38. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L and Shiloh Y. (2003). EMBO J., 22, 5612-5621.
39. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon P and Reis A. (1998). Cell, 93, 467-476.
40. Yazdi PT, Wang Y, Zhao S, Patel N, Lee EY and Qin J. (2002). Genes Dev., 16, 571-582.
41. Zhao S, Renthal W and Lee EY. (2002). Nucleic Acids Res., 30, 4815-4822.